The other cytokine, LT-β, was also identified in this study; LT-β has been shown to correlate with human oral cancer [89], and additionally, it activates the NIK-IKKa-RELB/NF-κB2 pathway to stimulate HNSCC cell migration [90,91]. This evidence concerns the gene RELB and lip and oral cavity carcinoma.